The effects of magnesium supplementation on abnormal uterine bleeding, alopecia, quality of life, and acne in women with polycystic ovary syndrome: a randomized clinical trial

[1] Dunaif A(1995)Hyperandrogenic anovulation (PCOS): A unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabes mellitus Am J Med. 98 33S-39S

[2] Okoroh EM(2012)Prevalence of polycystic ovary syndrome among the privately insured, United States, 2003–2008 Am J Obstet Gynecol 207 299.e1-299.e7

[3] Hooper WC(2013)Polycystic ovary syndrome: Definitions, phenotypes and diagnostic approach. In: Polycystic Ovary Syndrome: Novel Insights into Causes and Therapy. Front Horm Res. 40 1-21

[4] Atrash HK(2003)Prevalence of polycystic ovaries in women with androgenic alopecia Eur J Endocrinol 149 439-442

[5] Yusuf HR(2004)Hirsutism and acne in polycystic ovary syndrome Best Pract Res Clin Obstet Gynaecol 18 737-754

[6] Boulet SL(1995)Clinical, ultrasound and hormonal markers of androgenicity in acne vulgaris Br J Dermatol 133 249-253

[7] Livadas S(2010)Do South Asian women with PCOS have poorer health-related quality of life than Caucasian women with PCOS? A comparative cross-sectional study. Health Qual Life Outcomes. 8 149-1451

[8] Diamanti-Kandarakis E(2009)Prevalence and implications of anxiety in polycystic ovary syndrome: results of an internet-based survey in Germany Hum Reprod 24 1446-27

[9] Cela E(2013)The influence of a magnesium-rich marine extract on behaviour, salivary cortisol levels and skin lesions in growing pigs. Animal. 7 1017-60

[10] Robertson C(1989)[Magnesium–a new therapeutic alternative in primary dysmenorrhea] Zentralbl Gynakol. 111 755-61

[1] Dunaif A(1995)Hyperandrogenic anovulation (PCOS): A unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabes mellitus Am J Med. 98 33S-39S

[2] Okoroh EM(2012)Prevalence of polycystic ovary syndrome among the privately insured, United States, 2003–2008 Am J Obstet Gynecol 207 299.e1-299.e7

[3] Hooper WC(2013)Polycystic ovary syndrome: Definitions, phenotypes and diagnostic approach. In: Polycystic Ovary Syndrome: Novel Insights into Causes and Therapy. Front Horm Res. 40 1-21

[4] Atrash HK(2003)Prevalence of polycystic ovaries in women with androgenic alopecia Eur J Endocrinol 149 439-442

[5] Yusuf HR(2004)Hirsutism and acne in polycystic ovary syndrome Best Pract Res Clin Obstet Gynaecol 18 737-754

[6] Boulet SL(1995)Clinical, ultrasound and hormonal markers of androgenicity in acne vulgaris Br J Dermatol 133 249-253

[7] Livadas S(2010)Do South Asian women with PCOS have poorer health-related quality of life than Caucasian women with PCOS? A comparative cross-sectional study. Health Qual Life Outcomes. 8 149-1451

[8] Diamanti-Kandarakis E(2009)Prevalence and implications of anxiety in polycystic ovary syndrome: results of an internet-based survey in Germany Hum Reprod 24 1446-27

[9] Cela E(2013)The influence of a magnesium-rich marine extract on behaviour, salivary cortisol levels and skin lesions in growing pigs. Animal. 7 1017-60

[10] Robertson C(1989)[Magnesium–a new therapeutic alternative in primary dysmenorrhea] Zentralbl Gynakol. 111 755-61